Latest news with #KFSHRC
Mid East Info
3 days ago
- Health
- Mid East Info
A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care
In a rare example of a lifelong bond between a patient and a healthcare institution, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has continued to support a patient since infancy, providing 22 years of continuous care for a rare genetic blood clotting disorder, ultimately culminating in a liver transplant—the first of its kind globally for this particular condition. When the early signs of illness appeared during the patient's first months of life, KFSHRC teams raced against time to stabilize her condition. She was diagnosed with a congenital deficiency in plasminogen, a protein essential for dissolving blood clots, resulting in fibrous deposits that posed serious threats to her tissues and organs. The complexity of her case posed both medical and quality-of-life challenges, requiring a comprehensive, multidisciplinary care system. This extended beyond medical treatment to include all facets of life-supporting care. Teams from nursing, nutrition, and information technology joined hematology and transplant specialists to ensure the young girl's well-being. In a reflection on the early days, the patient's father said: 'My daughter suffered from the moment she was born. She cried constantly and couldn't nurse. We lived in continuous worry with no clear answers until God opened a door of hope. Today, thanks to God first, and then to the remarkable healthcare capabilities provided by the Government of the Custodian of the Two Holy Mosques and His Royal Highness the Crown Prince, may God preserve them, we witness our daughter's recovery from this rare disease after two decades of struggle.' Throughout the years of treatment, the patient relied on regular intravenous doses of plasminogen, along with eye drops to reduce the disease's effect on her vision. The annual cost of treatment exceeded 6 million SAR, fully covered by the Saudi government. This reflects the Kingdom's profound commitment to human health and its investment in quality of life even in the most complex medical cases. Dr. Hazzaa Al-Zahrani, Director of Adult Hematology and Stem Cell Transplant Division at KFSHRC Riyadh and the supervising physician, explained that managing the case required a precise and long-term approach to prevent complications and ensure stability. The decision to proceed with a liver transplant came after careful consideration as an extraordinary therapeutic option for an exceptionally rare case. The success of the procedure marked a turning point in her medical journey and a beacon of hope for patients facing similar conditions worldwide. This approach is deeply rooted in the vision of King Faisal Specialist Hospital & Research Centre, which places the patient at the core of every practice and is committed to delivering integrated care where scientific expertise meets human compassion, in line with its mission to serve society at the highest standards.
Web Release
3 days ago
- Health
- Web Release
A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care
In a rare example of a lifelong bond between a patient and a healthcare institution, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has continued to support a patient since infancy, providing 22 years of continuous care for a rare genetic blood clotting disorder, ultimately culminating in a liver transplant—the first of its kind globally for this particular condition. When the early signs of illness appeared during the patient's first months of life, KFSHRC teams raced against time to stabilize her condition. She was diagnosed with a congenital deficiency in plasminogen, a protein essential for dissolving blood clots, resulting in fibrous deposits that posed serious threats to her tissues and organs. The complexity of her case posed both medical and quality-of-life challenges, requiring a comprehensive, multidisciplinary care system. This extended beyond medical treatment to include all facets of life-supporting care. Teams from nursing, nutrition, and information technology joined hematology and transplant specialists to ensure the young girl's well-being. In a reflection on the early days, the patient's father said: 'My daughter suffered from the moment she was born. She cried constantly and couldn't nurse. We lived in continuous worry with no clear answers until God opened a door of hope. Today, thanks to God first, and then to the remarkable healthcare capabilities provided by the Government of the Custodian of the Two Holy Mosques and His Royal Highness the Crown Prince, may God preserve them, we witness our daughter's recovery from this rare disease after two decades of struggle.' Throughout the years of treatment, the patient relied on regular intravenous doses of plasminogen, along with eye drops to reduce the disease's effect on her vision. The annual cost of treatment exceeded 6 million SAR, fully covered by the Saudi government. This reflects the Kingdom's profound commitment to human health and its investment in quality of life even in the most complex medical cases. Dr. Hazzaa Al-Zahrani, Director of Adult Hematology and Stem Cell Transplant Division at KFSHRC Riyadh and the supervising physician, explained that managing the case required a precise and long-term approach to prevent complications and ensure stability. The decision to proceed with a liver transplant came after careful consideration as an extraordinary therapeutic option for an exceptionally rare case. The success of the procedure marked a turning point in her medical journey and a beacon of hope for patients facing similar conditions worldwide. This approach is deeply rooted in the vision of King Faisal Specialist Hospital & Research Centre, which places the patient at the core of every practice and is committed to delivering integrated care where scientific expertise meets human compassion, in line with its mission to serve society at the highest standards. For more information, visit or contact our media team at [email protected]
Zawya
3 days ago
- Health
- Zawya
A Life Rewritten: KFSHRC treats rare disease after 22 years of specialized care
In a rare example of a lifelong bond between a patient and a healthcare institution, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has continued to support a patient since infancy, providing 22 years of continuous care for a rare genetic blood clotting disorder, ultimately culminating in a liver transplant—the first of its kind globally for this particular condition. When the early signs of illness appeared during the patient's first months of life, KFSHRC teams raced against time to stabilize her condition. She was diagnosed with a congenital deficiency in plasminogen, a protein essential for dissolving blood clots, resulting in fibrous deposits that posed serious threats to her tissues and organs. The complexity of her case posed both medical and quality-of-life challenges, requiring a comprehensive, multidisciplinary care system. This extended beyond medical treatment to include all facets of life-supporting care. Teams from nursing, nutrition, and information technology joined hematology and transplant specialists to ensure the young girl's well-being. In a reflection on the early days, the patient's father said: 'My daughter suffered from the moment she was born. She cried constantly and couldn't nurse. We lived in continuous worry with no clear answers until God opened a door of hope. Today, thanks to God first, and then to the remarkable healthcare capabilities provided by the Government of the Custodian of the Two Holy Mosques and His Royal Highness the Crown Prince, may God preserve them, we witness our daughter's recovery from this rare disease after two decades of struggle.' Throughout the years of treatment, the patient relied on regular intravenous doses of plasminogen, along with eye drops to reduce the disease's effect on her vision. The annual cost of treatment exceeded 6 million SAR, fully covered by the Saudi government. This reflects the Kingdom's profound commitment to human health and its investment in quality of life even in the most complex medical cases. Dr. Hazzaa Al-Zahrani, Director of Adult Hematology and Stem Cell Transplant Division at KFSHRC Riyadh and the supervising physician, explained that managing the case required a precise and long-term approach to prevent complications and ensure stability. The decision to proceed with a liver transplant came after careful consideration as an extraordinary therapeutic option for an exceptionally rare case. The success of the procedure marked a turning point in her medical journey and a beacon of hope for patients facing similar conditions worldwide. This approach is deeply rooted in the vision of King Faisal Specialist Hospital & Research Centre, which places the patient at the core of every practice and is committed to delivering integrated care where scientific expertise meets human compassion, in line with its mission to serve society at the highest standards.
TECHx
5 days ago
- Health
- TECHx
U.S. Completes First Robotic Heart Transplant
Home » Smart Sectors » Healthcare » U.S. Completes First Robotic Heart Transplant Baylor St. Luke's Medical Center in Houston has announced the successful completion of the first fully robotic heart transplant in the United States. This achievement marks a historic step in global healthcare collaboration and robotic surgical innovation. The procedure closely follows a similar groundbreaking operation that was reported in September 2024 at King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh, Saudi Arabia. That operation, conducted under the leadership of Professor Feras Khaliel, was the world's first fully robotic heart transplant. It was performed on a 16-year-old patient with end-stage heart failure. The team used a chest-sparing, minimally invasive method. This novel technique, patented by Professor Khaliel, significantly lowers infection risk and speeds up recovery. This is especially critical for immunosuppressed transplant patients. KFSHRC has since applied the same robotic transplant technique to both adult and pediatric cases. • Professor Khaliel is now leading training efforts in the U.S. and Europe • The goal is to expand research and set new global surgical standards The American team's use of the technique developed in Riyadh signals growing international recognition of Saudi Arabia's role in medical innovation. Furthermore, it highlights the Kingdom's increasing influence in shaping the future of advanced healthcare delivery. Professor Khaliel and the leadership at KFSHRC were recently honored by His Royal Highness the Saudi Crown Prince and Prime Minister Mohammed bin Salman in recognition of this milestone. The robotic procedure has gained widespread media attention and global acclaim. It is being seen as a defining moment in the field of heart transplantation. This success has also triggered a wave of innovation in Saudi Arabia's healthcare sector. Experts report it is helping to reshape global clinical practice. As a result, Saudi Arabia is being viewed not only as a regional healthcare leader but as a global source of transformative medical models.
Web Release
6 days ago
- Health
- Web Release
Saudi-Born Breakthrough Sets the Stage for the USA's First Robotic Heart Transplant
In a landmark moment for global healthcare collaboration, Baylor St. Luke's Medical Center in Houston has announced the successful completion of the first fully robotic heart transplant in the United States. The procedure follows in the footsteps of a groundbreaking operation performed in September 2024 at King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh, Saudi Arabia—marking a significant milestone in the evolution of advanced surgical techniques. The Saudi-led procedure, conducted by a multidisciplinary team under the leadership of Professor Feras Khaliel, was the world's first fully robotic heart transplant. It was successfully performed on a 16-year-old patient with end-stage heart failure using a minimally invasive, chest-sparing technique. This novel approach, later patented by Professor Khaliel, significantly reduces infection risk and accelerates patient recovery—an especially critical advancement for immunosuppressed transplant recipients. The technique has since been applied at KFSHRC across both adult and pediatric cases. Professor Khaliel is now leading efforts to train institutions across the U.S. and Europe in this surgical innovation, with a focus on expanding clinical research and establishing new global standards for robotic complex and innovative procedures. The American surgical team's adoption of the method pioneered at KFSHRC signals international recognition of Saudi Arabia's leadership in high-impact medical innovation. It also underscores the growing global influence of the Kingdom in shaping the future of healthcare delivery. In recognition of this medical breakthrough, Professor Khaliel and the leadership team at KFSHRC were honored by His Royal Highness the Saudi Crown Prince and Prime Minister Mohammed bin Salman. The procedure has garnered international acclaim and widespread media attention, positioning it as a defining advancement in the field of heart transplantation. Importantly, this is not an isolated success. The Riyadh-based innovation has sparked a series of medical advancements and contributed to a broader shift in global clinical practice. As such, Saudi Arabia's healthcare sector is increasingly viewed not only as a regional leader but as a source of transformative models for medical care worldwide.
